ARMO BioSciences Files Registration Statement for Proposed Initial Public Offering

REDWOOD CITY, Calif., Dec. 29, 2017 /PRNewswire/ -- ARMO BioSciences, Inc., a late-stage immuno-oncology company, announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to a proposed initial public offering...